PHVS
PHVS
NASDAQ · Pharmaceuticals

Pharvaris Nv

$29.44
-1.57 (-5.06%)
As of May 9, 1:33 AM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 18 90%
Hold 2 10%
Sell 0 0%
Price Target
Analyst Price Target -23.9% upside
Low Target $12.72
Average Target $22.40
High Target $29.92
Current Price $29.44
Current
$29.44
Target
$22.40
$12.72 $22.40 avg $29.92
Scenario Analysis
Bear Case
$12.72
-56.8%
Low target
Base Case
$22.40
-23.9%
Avg target
Bull Case
$29.92
+1.6%
High target
Risk/Reward
0.0x
Unfavorable
Price in Context
52-Week High
$31.14
-5.5% from high
52-Week Low
$14.59
+101.9% from low
Target vs 52W High
$22.40
-28.1% vs high
Next Earnings Report
May 13, 2026 · After Market Close
2d
until earnings
EPS Est: $-0.73
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%